What We Do
As the research-based organisation for pharmaceutical SMEs, EMIG is engaged at the highest levels of government, regulatory bodies, the NHS and academic research establishments to ensure that patients are able to access and benefit from a wide range of innovative health technologies.
Because only c. 10% of our 260+ Members are represented by other trade bodies, EMIG brings an understanding right to the heart of policy development and decision-making of how SMEs contribute to innovation. It has been estimated that SMEs contribute 80% of innovation.
EMIG enables Members to connect and gain practical assistance through its extensive Membership network of over 260 companies and organisations. Examples include in-licensing and outsourcing opportunities.
EMIG is a member of The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), which was founded in 2008 to promote companies and associations active in research, development, production and distribution of pharmaceutical products and enhance their scientific, technical, economic and legal objectives across Europe.